Psychomotor Retardation, Spastic Paraplegia, Cerebellar Ataxia and Dyskinesia Associated with Low 5-Methyltetrahydrofolate in Cerebrospinal Fluid: A Novel Neurometabolic Condition Responding to Folinic Acid Substitution

Abstract

Introduction

Normal brain development and function depend on the active transport of folates across the blood-brain barrier. The folate receptor-1 (FR 1) protein is localized at the basolateral surface of the choroid plexus, which is characterized by a high binding affinity for circulating 5-methyltetrahydrofolate (5-MTHF).

Patients and Methods

We report on the clinical and metabolic findings among five children with normal neurodevelopmental progress during the first four to six months followed by the acquisition of a neurological condition which includes marked irritability, decelerating head growth, psychomotor retardation, cerebellar ataxia, dyskinesias (choreoathetosis, ballism), pyramidal signs in the lower limbs and occasional seizures. After the age of six years the two oldest patients also manifested a central visual disorder. Known disorders have been ruled out by extensive investigations. Cerebrospinal fluid (CSF) analysis included determination of biogenic monoamines, pterins and 5-MTHF.

Results

Despite normal folate levels in serum and red blood cells with normal homocysteine, analysis of CSF revealed a decline towards very low values for 5-methyltetrahydrofolate (5-MTHF), which suggested disturbed transport of folates across the blood-brain barrier. Genetic analysis of the FR 1 gene revealed normal coding sequences. Oral treatment with doses of the stable compound folinic acid (0.5 - 1 mg/kg/day Leucovorin®) resulted in clinical amelioration and normalization of 5-MTHF values in CSF.

Conclusion

Our findings identified a new condition manifesting after the age of 6 months which was accompanied by low 5-MTHF in cerebrospinal fluid and responded to oral supplements with folinic acid. However, the cause of disturbed folate transfer across the blood-brain barrier remains unknown.

Key words

Folate - Blood-Brain Barrier - Folate Receptor

References

• 1 Adams R D, Kubik C S. Subacute degeneration of the brain in pernicious anemia.  N Engl J Med. 1944;  231 1-9
• 2 Anderson R G, Kamen B A, Rothberg K G, Lacey S W. Potocytosis: sequestration and transport of small molecules by caveolae.  Science. 1992;  255 410-411
• 3 Atkinson I, Garrow T, Brenner A, Shane B. Human cytosolic folylpoly-γ-glutamate synthase.  Methods Enzymol. 1997;  281 134-140
• 4 Baethmann M, Wendel U, Hoffmann G F, Gohlich-Ratmann G, Kleinlein B, Seiffert P, Blom H, Voit T. Hydrocephalus internus in two patients with 5, 10-methylenetetrahydrofolate reductase deficiency.  Neuropediatrics. 2000;  31 314-317
• 5 Beckman D R, Hoganson G, Berlow S, Gilbert E F. Pathological findings in 5, 10-methylenetetrahydrofolate deficiency.  Birth Defects. 1987;  23 47-64
• 6 Blau N, Thöny B, Renneberg A, Penzien J M, Hyland K, Hoffmann G. Variant of dihydropteridine reductase deficiency without hyperphenylalaninemia: Effect of oral phenylalanine loading.  JIMD. 1999;  22 216-220
• 7 Blau N, Duran M, Blaskovics (eds) M. Physician's Guide to Laboratory Diagnosis of Metabolic Diseases. Chapter 2: Hyland K et al. Disorders of Neurotransmitter Metabolism. London; Chapman and Hall 1996: 79-98
• 8 Clayton P T, Smith I, Harding B, Hyland K, Leonard J V, Leeming R J. Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism.  J Neurol Neurosurg Psychiatr. 1986;  49 920-927
• 9 Corbeel L, Van den Berghe G, Jaeken J. et al . Congenital folate malabsorption.  Eur J Pediatr. 1985;  143 284-290
• 10 Curtius H C, Blau N, Kuster T. Pterins. Hommes FA Techniques in Diagnostic Human Biochemical Genetics. New York; Wiley-Liss 1991: 377-396
• 11 Czeizel A E, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation.  New Eng J Med. 1992;  327 1832-1835
• 12 De Marco P, Moroni A, Merello E. et al . Folate pathway gene alterations in patients with neural tube defects.  Am J Med Genet. 2000;  95 216-223
• 13 Elwood P C, Nachmanoff K, Saikawa Y. et al . The divergent 5′ termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promotors and alternative splicing: characterization of the alpha hFR Gene structure.  Biochemistry. 1997;  36 1467-1478
• 14 Fan J, Vitols K S, Huennekens F M. Multiple folate transport systems in L 1210 cells.  Adv Enzyme Regul. 1992;  32 3-15
• 15 Ghosh S K, Syed S K, Jung S, Paik W K, Kim S. Substrate specificity for myelin basic protein-specific protein methylase I.  Biochim Biophys Acta. 1990;  1039 142-148
• 16 Gospe S M, Gietzen D W, Summers P J. et al . Behavioral and neurochemical changes in folate-deficient mice.  Physiol Behav. 1995;  58 935-941
• 17 Heil S G, Van der Put N MJ, Trijbels F JM. et al . Molecular genetic analysis of human folate receptors in neural tube defects.  Eur J Hum Gen. 1999;  7 393-396
• 18 Holm J, Hansen S I, Hoier-Madsen M, Bostad L. High-affinity folate binding in human choroid plexus.  Biochem J. 1991;  280 267-271
• 19 Hyland K, Fryburg J S, Wilson W G. et al . Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test.  Neurology. 1997;  48 1290-1297
• 20 Ichinose H, Ohye T, Matsuda Y. et al . Characterization of mouse and human GTP cyclohydrolase I gene mutations in patients with GTP cyclohydrolase I deficiency.  J Biol Chem. 1995;  270 10062-10071
• 21 Kamen B A, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content.  Proc Natl Acad Sci USA. 1986;  83 5983-5987
• 22 Kane M A, Elwood P C, Portillo R M, Antony A C, Najfeld V, Finley A, Waxman S, Kolhouse J F. Influence on immunoreactive folate-binding protein of extracellular folate concentration in cultured human cells.  J Clin Invest. 1988;  81 1398-1406
• 23 Lever E G, Elwes R DC, Williams A, Reynolds E H. Subacute combined degeneration of the cord due to folate deficiency: response to methyl-folate treatment.  J Neurol Neurosurg Psychiatr. 1986;  49 1203-1207
• 24 Mineo C, Anderson R GW. Potocytosis. Robert Feulgen lecture.  Histochem Cell Biol. 2001;  116 109-118
• 25 Piedrahita J A, Oetama B, Bennett G D, van Waes J. et al . Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development.  Nature genetics. 1999;  23 228-232
• 26 Prasad P D, Ramamoorthy S, Moe A J. et al . Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells.  Biochim Biophys Acta Molecular Cell Res. 1994;  1223 71-75
• 27 Ramaekers Th V, Senderek J, Häusler M. et al . A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophane and carbidopa.  Mol Genet Metab. 2001;  73 179-187
• 28 Rosenblatt D. Inherited disorders of folate transport and metabolism. Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY; McGraw-Hill 1995: 3111-3128
• 29 Rothberg K G, Ying Y, Kolhouse J F. et al . The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytotic pathway.  J Cell Biology. 1990;  110 637-649
• 30 Said H M, Nguyen T T, Dyer D L. et al . Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA.  Biochim Biophys Acta Biomembranes. 1996;  1281 164-172
• 31 Selhub J. Folate binding proteins. Mechanism for placental and intestinal uptake. Allen L, King J, Lönnerdal B Nutrient Relation During Pregnancy, Lactation and Infant Growth. New York; Plenum Press 1994: 141-149
• 32 Shen F, Ross J F, Wang X. et al . Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells - cDNA cloning, expression, immunoreactivity and tissue specificity.  Biochemistry. 1994;  33 1209-1215
• 33 Spector R, Lorenzo A. Folate transport in the central nervous system.  Am J Physiol. 1975;  229 777-782
• 34 Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid.  J Neurochem. 1989;  53 1667-1674
• 35 Surtees R. Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain.  JIMD. 1993;  16 762-770
• 36 Surtees R, Heales S, Bowron A. Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine.  Clin Sci (Colch). 1994;  86 697-702
• 37 Urbach J, Abrahamor A, Grossowicz N. Congenital isolated folic acid malabsorption.  Arch Dis Child. 1987;  62 78-80
• 38 Wang T TY, Chandler C J, Halsted C H. Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa: isolation and characterization.  J Biol Chem. 1986;  261 13551-13555
• 39 Wang Y, Zhao R, Russell R G, Goldman I D. Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis.  Biochim Biophys Acta. 2001;  1513 49-54
• 40 Weitman S D, Lark R H, Coney L R, Fort D W, Frasca V, Zurawski V R, Kamen B A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.  Cancer Res. 1992;  52 3396-3401
• 41 Weitman S D, Weinberg A G, Coney L R. et al . Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.  Cancer Res. 1992;  52 6708-6711
• 42 Wevers R A, Hansen S I, Hubar J LMV. et al . Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system.  J Neurol Neurosurg Psychiatr. 1994;  57 223-226
• 43 Wu D, Pardridge W M. Blood-brain barrier transport of reduced folic acid.  Pharm Res. 1999;  16 415-419
• 44 Young S N. The 1989 Borden Award Lecture. Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior.  Can J Physiol Pharmacol. 1991;  69 893-903